2022 is a special year for the development of world cardiology: two important events are celebrated, namely the 40th anniversary of the first percutaneous angioplasty performed by Andreas Gruentzig (Switzerland) in September 1977 and the 20th anniversary of the first successful transcatheter aortic valve implantation (TAVI) in humans. Undoubtedly, these two techniques changed the development of the cardiovascular field of medicine for many decades. The spread of aortic stenosis, as the most common acquired heart disease, allows us to understand the importance of the latest methods of its correction. The growing prevalence of use and changes in indications for this operation require the collaboration of specialists in various specialties: cardiologists, cardiac surgeons, anesthesiologists, resuscitators, perfusiologists, rheumatologists, electrophysiologists and others. To implement the method in medical institutions, separate teams of doctors «Heart Team» are created that not only participate in the selection of patients, but also participate in the implementation of TAVI. Gaining experience, creating an optimal design and reducing the diameter of the delivery catheters has led to a reduction in the incidence of complications and the possibility of use in lower risk groups.
The contemporary data regarding the role of the thoracic endovascular aneurysm repair (TEVAR) in patients with connective tissue disorders (CTD) are reviewed. We performed search of the data in electronic databases PubMed, SCOPUS, Embase, Google Scholar OVID, related to the use of TEVAR. Currently, there is a limited amount of large cohort size studies outlining the use of TEVAR in patients with CTD. Endovascular prosthetics of the thoracic aorta in patients with accidents is dangerous because of the progressive dilatation of the aorta and the high probability of further re-interventions in later life. The analysis showed that open reconstruction still remains a gold standard of intervention in young patients with progressive CTDs, especially in acute type of aortic dissection. However, long-term data need to be published to support this practice.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.